0 items USD 0.00Search
Your search for "globaldata chronic myelocytic leukemia cml chronic myeloid leukemia global clinical trials review h1" gave back 763000 results.
Acute lymphoblastic leukemia (ALL) is a malignant tumor disease in which B or T cells of lymphocytes proliferate abnormally in the bone marrow...
Catalog:
MRRPB5
March 2024
Price: USD 3,950.00
Myelofibrosis or osteomyelofibrosis is a myeloproliferative disorder which is characterized by proliferation of abnormal clone of hematopoietic stem...
Catalog:
MRRPB5
May 2023
Price: USD 4,900.00
hronic myeloproliferative disorders are rare hematological malignances that involve abnormal accumulation of mature myeloid cells (red blood cells,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Imbruvica market size was valued at US$ million in 2023. With growing demand in downstream market, the Imbruvica is forecast to a...
Catalog:
LPI
February 2024
Price: USD 3,660.00
The full name of BET inhibitor is BET protein family inhibitor, which refers to drugs that can inhibit BET protein family isomers such as BRDT, BRD2...
Catalog:
MRRPB5
February 2024
Price: USD 2,900.00
Erwinase is used in combination with other anti-neoplastic agents to treat acute lymphoblastic leukaemia. It may also be used in other neoplastic...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin...
Catalog:
MRRPB5
March 2024
Price: USD 3,950.00
Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Asparaginase is an enzyme, as a medication it is used to treat acute lymphoblastic leukemia (ALL), acute myeloid leukemia (AML), and non-Hodgkin...
Catalog:
MRRPB5
November 2023
Price: USD 4,350.00
Acute lymphoblastic leukemia (ALL) is a cancer of white blood cells called as lymphocytes in bone marrow. It is a malignant disease in which early...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Acute Lymphocytic Leukemia (ALL) Treatment market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
Hairy cell leukemia is a rare type of cancer of blood which is caused due to abnormal growth of B cells. The global Hairy cell Leukemia Treatment...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
The global Leukemia Inhibitory Factor (LIF) market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of...
Catalog:
MRRPB5
November 2023
Price: USD 2,900.00
